Women Turn to Unapproved Peptides to Alleviate Menopause Symptoms
A growing number of women are self-administering synthetic peptides sold for research use to manage menopause-related issues, despite limited clinical testing and regulatory oversight.
Women experiencing menopause are increasingly purchasing synthetic peptides marketed for research use and using them without medical supervision. The trend has emerged from online communities where users share personal protocols and slang to avoid platform moderation.
Stephanie Corn, 56, reported that after undergoing chemically induced menopause she suffered memory loss, hot flashes and joint pain. She began ordering peptides online after seeing a Facebook comment and consulting an AI chatbot. Corn says the substances have improved her mood, energy and daily functioning, though she experienced a nerve injury from an injection.
Endocrinologist Dr. Rachel Pessah-Pollack of NYU Langone noted that many patients seek alternative treatments because conventional options often leave menopausal symptoms undertreated. "I have patients come in on a daily basis with questions about what they’re seeing online," she said.
Jay Campbell, co-founder of BioLongevity Labs, an e-commerce seller of peptides, described the compounds as "tools" rather than cures, emphasizing that benefits depend on responsible use. However, he warned that the market includes scammers and products that may contain incorrect ingredients or dosages.
Women such as Darla Allison, 45, and Lacretia Riekeberg, 47, have experimented with various peptide blends, reporting relief from joint pain, weight gain and brain fog, but also adverse effects like swelling from overdosing. Some users have turned to experimental drugs such as retatrutide, which is not FDA-approved but is sold online for research purposes.
Medical professionals caution that combining multiple untested peptides can pose health risks. "There are people stacking multiple compounds that we’ve never studied in humans, using very high doses that are potentially harmful," Dr. Pessah-Pollack added.
The FDA has issued warnings about mislabeled or contaminated peptide products, and experts advise individuals to consult qualified physicians before using such substances. The practice remains largely unregulated, leaving users to navigate a gray market with limited safety data.